Stock listing
LSE:0RA9 Abivax SA Share Price
UK listing (LSE) of Abivax SA · home listing Euronext:ABVX
Follow Abivax SA into a list and get an email when it puts out news.
Share price · LSE:0RA9
€75.15 EUR -1.75 (-2.3%)
Close on Nov 17, 2026
- Day range
- €74.60 – €76.00 EURNov 17, 2026
- Volume
- 2,062 sharesNov 17, 2026
- Market cap
- €834.7M EURAt the close on Nov 17, 2026 · price × 11.11M shares outstanding
- 52-week range
- €60.70 – €139.00 EURLowest and highest trades, Nov 18, 2025 – Nov 17, 2026
- Traded on an average day
- €367,909 EURMedian day 800 shares · last 3 months, Aug 17, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Euronext:ABVX · Home | €75.50 EUR | -1.40 (-1.8%) | 128,059 | €75.20 | €76.15 | €74.25 | €76.90 | Close on Nov 17, 2026 |
| NASDAQ:ABVX | $82.10 USD | -1.51 (-1.8%) | 1,372,710 | $82.86 | $84.31 | $81.83 | $83.61 | Close on Nov 17, 2026 |
| LSE:0RA9 | €75.15 EUR | -1.75 (-2.3%) | 2,062 | €76.00 | €76.00 | €74.60 | €76.90 | Close on Nov 17, 2026 |
| OTC:AAVXF | $84.80 USD | 0.00 (0.0%) | — | $84.80 | $84.80 | $84.80 | $84.80 | Close on Nov 6, 2026 |
| Frankfurt:2X1 | €77.00 EUR | +1.15 (+1.5%) | 101 | €74.65 | €77.00 | €74.65 | €75.85 | Close on Nov 17, 2026 |
| Frankfurt:2X10 | €74.00 EUR | -3.50 (-4.5%) | 40 | €74.00 | €74.00 | €74.00 | €77.50 | Close on Nov 17, 2026 |
Daily closes
Last 3 months, Aug 17, 2026 – Nov 6, 2026 · LSE:0RA9 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €76.50 | +0.30 | +0.4% | €74.45 | €76.50 | €73.90 | 2,082 | |
| €76.20 | -4.55 | -5.6% | €80.85 | €82.80 | €76.20 | 1,456 | |
| €80.75 | +0.95 | +1.2% | €79.60 | €80.75 | €79.60 | 1,015 | |
| €79.80 | +2.00 | +2.6% | €75.50 | €80.05 | €75.35 | 18,406 | |
| €77.80 | -1.25 | -1.6% | €78.00 | €78.20 | €77.40 | 332 | |
| €79.05 | -2.40 | -2.9% | €80.30 | €80.30 | €78.00 | 8,009 | |
| €81.45 | +1.40 | +1.7% | €80.35 | €82.50 | €80.35 | 209 | |
| €80.05 | +0.15 | +0.2% | €80.60 | €80.60 | €79.40 | 15 | |
| €79.90 | +1.90 | +2.4% | €77.65 | €79.95 | €77.40 | 261 | |
| €78.00 | -0.55 | -0.7% | €79.10 | €80.00 | €78.00 | 754 | |
| €78.55 | -4.05 | -4.9% | €81.45 | €81.45 | €78.00 | 80 | |
| €82.60 | -1.75 | -2.1% | €81.50 | €82.95 | €81.50 | 848 | |
| €84.35 | +1.10 | +1.3% | €83.25 | €85.60 | €83.25 | 737 | |
| €83.25 | +5.15 | +6.6% | €78.55 | €83.25 | €78.55 | 601 | |
| €78.10 | -0.50 | -0.6% | €79.80 | €79.80 | €73.00 | 3,519 | |
| €78.60 | -3.40 | -4.1% | €82.45 | €82.60 | €78.60 | 53 | |
| €82.00 | +4.50 | +5.8% | €78.60 | €82.35 | €78.00 | 20 | |
| €77.50 | +0.925 | +1.2% | €77.50 | €77.50 | €77.50 | 218 | |
| €76.58 | -0.825 | -1.1% | €77.50 | €78.00 | €75.60 | 14,272 | |
| €77.40 | -2.45 | -3.1% | €78.55 | €78.75 | €77.40 | 16 | |
| €79.85 | +2.75 | +3.6% | €79.95 | €79.95 | €79.00 | 112,933 | |
| €77.10 | -1.50 | -1.9% | €76.80 | €77.45 | €75.90 | 19,435 | |
| €78.60 | -1.95 | -2.4% | €78.75 | €78.90 | €77.55 | 2,526 | |
| €80.55 | +0.25 | +0.3% | €81.65 | €83.10 | €78.90 | 275 | |
| €80.30 | -3.20 | -3.8% | €83.25 | €83.40 | €80.00 | 42 | |
| €83.50 | -0.65 | -0.8% | €84.00 | €84.38 | €83.05 | 1,013 | |
| €84.15 | -3.90 | -4.4% | €87.30 | €87.30 | €83.55 | 10,295 | |
| €88.05 | +3.30 | +3.9% | €85.95 | €88.05 | €85.25 | 2,380 | |
| €84.75 | +0.95 | +1.1% | €84.50 | €86.30 | €84.50 | 2,369 | |
| €83.80 | +2.25 | +2.8% | €80.85 | €83.85 | €79.85 | 2,137 | |
| €81.55 | -0.05 | -0.1% | €83.40 | €83.40 | €81.05 | 70 | |
| €81.60 | -2.35 | -2.8% | €82.60 | €83.50 | €81.00 | 1,625 | |
| €83.95 | -2.50 | -2.9% | €85.90 | €86.50 | €83.95 | 5,311 | |
| €86.45 | -4.20 | -4.6% | €89.00 | €90.65 | €84.80 | 297 | |
| €90.65 | -0.20 | -0.2% | €92.30 | €92.75 | €90.45 | 1,263 | |
| €90.85 | -2.25 | -2.4% | €94.05 | €94.05 | €90.85 | 1,635 | |
| €93.10 | +2.15 | +2.4% | €90.95 | €93.10 | €89.55 | 461 | |
| €90.95 | -2.25 | -2.4% | €93.50 | €93.75 | €89.40 | 579 | |
| €93.20 | -6.55 | -6.6% | €98.30 | €98.30 | €92.55 | 156 | |
| €99.75 | -1.55 | -1.5% | €101.50 | €102.00 | €99.15 | 7,522 | |
| €101.30 | +0.90 | +0.9% | €98.70 | €101.30 | €98.65 | 845 | |
| €100.40 | -0.40 | -0.4% | €104.40 | €104.80 | €100.40 | 4,429 | |
| €100.80 | +1.40 | +1.4% | €101.50 | €101.50 | €100.80 | 1,425 | |
| €99.40 | +1.55 | +1.6% | €98.05 | €99.50 | €98.00 | 128 | |
| €97.85 | +0.65 | +0.7% | €98.95 | €99.60 | €97.85 | 735 | |
| €97.20 | -2.45 | -2.5% | €98.30 | €98.90 | €97.20 | 990 | |
| €99.65 | +2.90 | +3.0% | €97.10 | €99.65 | €96.60 | 31 | |
| €96.75 | +0.95 | +1.0% | €98.05 | €98.65 | €96.75 | 188 | |
| €95.80 | -1.25 | -1.3% | €96.30 | €96.30 | €95.00 | 478 | |
| €97.05 | -1.385 | -1.4% | €97.40 | €98.05 | €96.50 | 13,937 | |
| €98.44 | -1.655 | -1.7% | €98.60 | €99.35 | €97.92 | 6,124 | |
| €100.09 | -0.509 | -0.5% | €100.60 | €101.40 | €99.86 | 443 | |
| €100.60 | -2.90 | -2.8% | €100.80 | €101.80 | €99.80 | 288 | |
| €103.50 | +5.20 | +5.3% | €101.80 | €103.90 | €100.80 | 69 | |
| €98.30 | -3.50 | -3.4% | €99.00 | €99.15 | €97.45 | 5,713 | |
| €101.80 | +1.50 | +1.5% | €101.80 | €102.20 | €100.50 | 851 | |
| €100.30 | -3.10 | -3.0% | €104.90 | €105.00 | €100.00 | 2,354 | |
| €103.40 | +0.30 | +0.3% | €103.20 | €103.60 | €102.60 | 38 | |
| €103.10 | -1.50 | -1.4% | €105.10 | €105.40 | €103.10 | 166 | |
| €104.60 | +1.90 | +1.9% | €103.20 | €104.60 | €103.20 | 379 |
- Ticker
- LSE:0RA9
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- EUR
What changed lately
Latest news release · Nov 2, 2026
Abivax to Participate in Upcoming Fall Investor Conferences
Latest deck · July 2026
Investor Presentation (July 2026)
Investor deck · 87 slides
Calls
Replays
Abivax (Euronext:ABVX) Q4 2023 Earnings Call
Mon, Apr 08, 2024 · 8:30 AM ET
Watch Transcript
Latest news
Abivax to Participate in Upcoming Fall Investor Conferences
Nov 2, 2026
Closed €79.80 (+2.6%) on Nov 3, 2026
Abivax participera à plusieurs conférences investisseurs cet automne
Nov 2, 2026
Closed €77.80 (-1.6%) on Nov 2, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.26
Oct 23, 2026
Closed €78.55 (-4.9%) on Oct 23, 2026
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed €84.15 (-4.4%) on Oct 1, 2026
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Sep 30, 2026
Closed €88.05 (+3.9%) on Sep 30, 2026
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Sep 25, 2026
Closed €81.55 (-0.1%) on Sep 25, 2026
Abivax Presents Business Updates and First Half 2026 Financial Results
Sep 21, 2026
Closed €86.45 (-4.6%) on Sep 22, 2026
Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod
Jul 30, 2026
Closed €106.30 (-1.9%) on Jul 31, 2026
Abivax Strengthens Commercial Capabilities With Strategic Leadership Appointments
Jul 23, 2026
Closed €112.80 (-1.3%) on Jul 24, 2026
Abivax Announces Closing of $920 Million Public Offering
Jul 6, 2026
Closed €126.80 (-2.2%) on Jul 7, 2026
Financings
Public offering of american Depositary Shares
Jul 6, 2026
Closed: US$920M raised · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley (co-lead), Piper Sandler (co-lead), Guggenheim Securities (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Together with existing cash, to finance operations into the fourth quarter of 2029
Public offering of american Depositary Shares
Jul 2, 2026
Made bigger: about US$920M · US$125 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Morgan Stanley & Co. LLC (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, Van Lanschot Kempen
Use of proceeds: Potential US commercialization of obefazimod, clinical R&D mainly in ulcerative colitis and Crohn's disease, and general corporate purposes
Announced Jun 30, 2026 · Made bigger Jul 1, 2026 · Made bigger Jul 2, 2026
Public offering of american Depositary Shares
Jul 28, 2025
Closed: US$747.5M raised · US$64 a share · Leerink Partners +5
Dealers: Leerink Partners (co-lead), Piper Sandler & Co. (co-lead), Guggenheim Securities, LLC (co-lead), LifeSci Capital, BTIG, Van Lanschot Kempen
Use of proceeds: Finance operations into the fourth quarter of 2027, giving 12 months of cash runway after the planned NDA submission for Ulcerative Colitis
Announced Jul 23, 2025 · Update Jul 24, 2025 · Made bigger Jul 25, 2025 · Closed Jul 28, 2025
Decks
Investor Presentation (July 2026)
Investor deck · 87 slides · July 2026
Corporate Update (June 2026)
Corporate update · 56 slides · Jun 29, 2026
Investor Presentation (June 2023)
Investor deck · 35 slides · June 2023
Investor Presentation (May 2023)
Investor deck · 35 slides · May 2023
Abivax SA on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 30 in the last 12 months · 49 in all · newest Nov 2, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Apr 8, 2024
- Decks
- 39 decks · latest July 2026
Where Abivax SA is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Euronext:ABVX · Home listing | Euronext | France | EUR |
| NASDAQ:ABVX | NASDAQ | United States | USD |
| LS Exchange:A14UQC | LS Exchange | Germany | EUR |
| gettex:2X1 | gettex | Germany | EUR |
| LSE:0RA9 · This page | LSE | United Kingdom | EUR |
| Xetra:2X1 | Xetra | Germany | EUR |
| Tradegate:2X1 | Tradegate | Germany | EUR |
| OTC:AAVXF | OTC | United States | USD |
| Lang & Schwarz:A14UQC | Lang & Schwarz | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| Frankfurt:2X1 | Frankfurt | Germany | EUR |
| gettex:2X10 | gettex | Germany | EUR |
| BX Swiss:ABVX | BX Swiss | Switzerland | CHF |
| Dusseldorf:2X1 | Dusseldorf | Germany | EUR |
| Lang & Schwarz:A3EWCP | Lang & Schwarz | Germany | EUR |
| Munich:2X1 | Munich | Germany | EUR |
| Hamburg:2X1 | Hamburg | Germany | EUR |
| Aquis:ABVXP | Aquis | United Kingdom | EUR |
| BOATS:ABVX | BOATS | United States | USD |
| Frankfurt:2X10 | Frankfurt | Germany | EUR |
| LS Exchange:A3EWCP | LS Exchange | Germany | EUR |
| Stuttgart:2X1 | Stuttgart | Germany | EUR |
| Turquoise:ABVXP | Turquoise | United Kingdom | EUR |
| VIE:ABVX | Vienna | Austria | EUR |
| Dusseldorf:2X10 | Dusseldorf | Germany | EUR |
| Hamburg:2X10 | Hamburg | Germany | EUR |
| Munich:2X10 | Munich | Germany | EUR |
| Stuttgart:2X10 | Stuttgart | Germany | EUR |
| Tradegate:2X10 | Tradegate | Germany | EUR |
| Hanover:2X1 | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Abivax SA.